BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal Pharmaceuticals today announced the company was recently honored with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA) for Generic Pharmaceutical Product Manufacturer with Sales to Healthcare Distributors of More Than $100 Million by the Healthcare Distribution Alliance (HDA). This award, which is selected by healthcare distributors, recognizes pharmaceutical manufacturers who exemplify the standard of excellence in best business practices with HDA healthcare distributors.

“We are honored to be recognized by our customers for our contributions to enhance the healthcare supply chain,” said Chirag Patel, co-CEO and chairman, Amneal Pharmaceuticals. “Receiving this recognition is not only an important validation of our collaborative business approach, but it also is a reflection of the commitment and hard work of our employees who work closely with our customers to bring high-quality products to pharmacists, physicians and patients.”

According to IMS Health, Amneal Pharmaceuticals is now the seventh largest generics company in the U.S., by prescriptions, and the fastest-growing manufacturer globally, with a diversified portfolio that includes 115 U.S. FDA-approved molecules and approximately 170 in development.

About Amneal

Amneal Pharmaceuticals, a privately-held company headquartered in Bridgewater, New Jersey, is the fastest growing generics pharmaceutical manufacturer in the world. Founded in 2002, Amneal has now more than 4,000 employees in its operations in North America, Asia, Australia and Europe, working together to bring high-quality, affordable medicines worldwide. Amneal has significantly expanded its portfolio of generic products to include complex dosage forms in a broad range of therapeutic areas. For more information, visit www.amneal.com.